Amarin’s Vascepa: US FDA Panel To Scrutinize Breadth Of CV Risk Reduction

 
• By Sue Sutter
  
PS1911_Big-game-fishing_223578337_1200.jpg
Amarin is hoping to finally reel in the big indication for its fish oil-derived drug Vascepa. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers